National Research Net Worth
National Research Net Worth Breakdown | NRC |
National Research Net Worth Analysis
National Research's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including National Research's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of National Research's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform National Research's net worth analysis. One common approach is to calculate National Research's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares National Research's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing National Research's net worth. This approach calculates the present value of National Research's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of National Research's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate National Research's net worth. This involves comparing National Research's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into National Research's net worth relative to its peers.
Enterprise Value |
|
To determine if National Research is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding National Research's net worth research are outlined below:
| National Research generated a negative expected return over the last 90 days | |
| National Research has a frail financial position based on the latest SEC disclosures | |
| About 37.0% of the company outstanding shares are owned by corporate insiders | |
| On 11th of October 2024 National Research paid $ 0.12 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: National Research Will Want To Turn Around Its Return Trends |
National Research Quarterly Good Will |
|
National Research uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in National Research Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to National Research's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Know National Research's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as National Research is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading National Research Corp backward and forwards among themselves. National Research's institutional investor refers to the entity that pools money to purchase National Research's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Millennium Management Llc | 2024-06-30 | 214.9 K | Wells Fargo & Co | 2024-06-30 | 179.1 K | Hotchkis & Wiley Capital Management Llc | 2024-09-30 | 138.2 K | Northwest & Ethical Investments L.p. | 2024-09-30 | 129.2 K | Eagle Asset Management, Inc. | 2024-06-30 | 124.8 K | Charles Schwab Investment Management Inc | 2024-09-30 | 123.7 K | Bank Of New York Mellon Corp | 2024-06-30 | 123.3 K | Bank Of America Corp | 2024-06-30 | 120.9 K | Comerica Bank | 2024-09-30 | 99.8 K | Kayne Anderson Rudnick Investment Management Llc | 2024-06-30 | 3 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.8 M |
Follow National Research's market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 457.31 M.Market Cap |
|
Project National Research's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.52 | 0.55 | |
| Return On Capital Employed | 0.46 | 0.28 | |
| Return On Assets | 0.25 | 0.20 | |
| Return On Equity | 0.63 | 0.48 |
When accessing National Research's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures National Research's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of National Research's profitability and make more informed investment decisions.
Please note, the presentation of National Research's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, National Research's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of National Research's management manipulating its earnings.
Evaluate National Research's management efficiency
National Research Corp has Return on Asset of 0.1853 % which means that on every $100 spent on assets, it made $0.1853 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.5856 %, implying that it generated $0.5856 on every 100 dollars invested. National Research's management efficiency ratios could be used to measure how well National Research manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.55, whereas Return On Capital Employed is forecasted to decline to 0.28. At present, National Research's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Return On Tangible Assets is expected to grow to 0.55, whereas Total Assets are forecasted to decline to about 80.7 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.99 | 2.83 | |
| Tangible Book Value Per Share | (0.58) | (0.55) | |
| Enterprise Value Over EBITDA | 21.81 | 36.71 | |
| Price Book Value Ratio | 19.83 | 35.82 | |
| Enterprise Value Multiple | 21.81 | 36.71 | |
| Price Fair Value | 19.83 | 35.82 | |
| Enterprise Value | 834.1 M | 875.8 M |
The strategic initiatives led by National Research's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Enterprise Value Revenue 3.5204 | Revenue 144.2 M | Quarterly Revenue Growth (0.06) | Revenue Per Share 6.013 | Return On Equity 0.5856 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific National Research insiders, such as employees or executives, is commonly permitted as long as it does not rely on National Research's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases National Research insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
National Research Corporate Filings
8K | 14th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 13th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
10Q | 8th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F4 | 10th of May 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
National Research Earnings per Share Projection vs Actual
National Research Corporate Management
| CPA CPA | CFO, Fin | Profile | |
| Jennifer Baron | Chief Officer | Profile | |
| Gregory MS | Chief Officer | Profile | |
| Linda Stacy | Principal Officer | Profile | |
| Jona Raasch | Chief Officer | Profile | |
| Jon Boumstein | Chief Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Research Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Research. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Research listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.25) | Dividend Share 0.48 | Earnings Share 1.12 | Revenue Per Share 6.013 | Quarterly Revenue Growth (0.06) |
The market value of National Research Corp is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Research's value that differs from its market value or its book value, called intrinsic value, which is National Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Research's market value can be influenced by many factors that don't directly affect National Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.